Entresto Trade Dress Dispute: No Injunctive Relief for Novartis
On July 15, 2025, Judge Evelyn Padin of the District of New Jersey denied Novartis’s motion for preliminary injunction, which would have...
FTC Peeling Back the Layers of the Orange Book
The Federal Trade Commission (FTC) is continuing to pursue pharmaceutical manufacturers for allegedly improperly listing patents in the...
Compounding Problems: Recent Decisions on Tirzepatide Highlight Interplay Between FDA Anti-Compounding Enforcement and Private Intellectual Property Rights
Earlier this month, a federal district court denied the Outsourcing Facilities Association’s preliminary injunction motion, which sought...
Pounding the Compounders: FDA’s “No Compound” Lists
Novo Nordisk recently made headlines petitioning FDA to stop the compounding of its blockbuster GLP-1 products so it can sell its...
Federal Circuit Provides Useful Guidance on Skinny Label Claims
When the Federal Circuit resurrected Amarin’s “skinny label” infringement claims against Hikma last month, it offered some important...
As a free user, you can like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net